EluNIR Ridaforolimus Eluting Coronary Stent System LUN275R17USRecalls & reported problems
Medinol Ltd. · Class 3 · Implant
All models of EluNIR Ridaforolimus Eluting Coronary Stent System (27)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290107013628), received between Dec 4, 2019 and Dec 4, 2019 — classified as 1 malfunction.
The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Deformation Due to Compressive Stress1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 4, 2019Deformation Due to Compressive Stress; Deformation Due to Compressive Stress
INITIAL INFORMATION RECEIVED FROM THE DISTRIBUTOR ON (B)(6) 2019 HAVE INDICATED THE PHYSICIAN HAVE ATTEMPTED TO USE THE SYSTEM RECENTLY AND THE SHAFT KINKED DURING INSERTION. THERE WAS NO PATIENT INJURY, AND HE FINISHED THE CASE WITH ANOTHER STENT. FURTHER INFORMATION WAS AVAILABLE IN THE DETAILED COMPLAINT REPORT RECEIVED ON (B)(6) 2019 AS FOLLOWS: "AS REPORTED BY THE SALES REP, PLEASE SEND A NEW 2.75X17 ELUNIR TO (B)(6) MEDICAL CENTER 10019386. SEND OVERNIGHT ATTENTION TO (B)(6)/CATH LAB. THE DR. ATTEMPTED TO USE THIS RECENTLY AND THE SHAFT KINKED DURING INSERTION. " THERE WAS NO PATIENT INJURY, AND HE FINISHED THE CASE WITH ANOTHER STENT."
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9410117 ↗
Other Coronary Drug-Eluting Stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page